Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Tipo de estudo
Intervalo de ano de publicação
1.
Genet Mol Res ; 14(4): 13799-811, 2015 Oct 29.
Artigo em Inglês | MEDLINE | ID: mdl-26535695

RESUMO

The aim of this study was to explore the precise role of retinoic acid-inducible gene-I (RIG-I) signaling in human immunodeficiency virus type 1 (HIV-1)-infected macrophages from patients with HIV-1-associated neurocognitive disorders (HAND). Postmortem brain tissues were collected from patients with HIV-1-associated dementia and were compared to samples collected from HIV serum-positive patients without dementia and HIV serum-negative patients. A human monocyte-derived macrophage (MDM) primary culture system was established to evaluate the expression of RIG-I in these samples. Knockdown of RIG-I pathways genes was employed and STAT1 expression and phosphorylation levels were examined to explore the molecular mechanisms of HAND. The expression of RIG-I in postmortem brain tissue from HAND patients was significantly higher than in patients who were HIV serum-positive without dementia or HIV serum-negative. Moreover, we demonstrated that HIV-1 infection could result in a significant increase in the level of RIG-I in human MDMs. Moreover, a correlation was found between the increase in RIG-I expression and STAT1 expression and phosphorylation. Accordingly, knockdown of RIG-I decreased the phosphorylation of STAT1 and downregulated interferon-related genes. These observations highlight the importance of RIG-I signaling in anti-HIV innate immunity in macrophages, which may be beneficial for the treatment of HIV and aid in the understanding of the neuropathogenesis of HAND.


Assuntos
RNA Helicases DEAD-box/metabolismo , Infecções por HIV/complicações , Infecções por HIV/virologia , HIV-1 , Interferon Tipo I/metabolismo , Macrófagos/metabolismo , Transtornos Neurocognitivos/etiologia , Transtornos Neurocognitivos/metabolismo , Encéfalo/metabolismo , Proteína DEAD-box 58 , RNA Helicases DEAD-box/genética , Expressão Gênica , Técnicas de Silenciamento de Genes , Infecções por HIV/imunologia , Infecções por HIV/metabolismo , Humanos , Interferon Tipo I/genética , Helicase IFIH1 Induzida por Interferon , Macrófagos/imunologia , Macrófagos/virologia , RNA de Cadeia Dupla/metabolismo , RNA Mensageiro/genética , RNA Mensageiro/metabolismo , Receptores Imunológicos , Fator de Transcrição STAT1/metabolismo , Transdução de Sinais , Replicação Viral
2.
Genet Mol Res ; 14(4): 12386-93, 2015 Oct 16.
Artigo em Inglês | MEDLINE | ID: mdl-26505388

RESUMO

Intervertebral disc degeneration is the main cause of lumbago disease, in which the extracellular matrix structure and moisture in the nucleus pulposus is lost continuously. In this study, we aimed to detect differential expression of silence mating type information regulation 2 homolog 1 (SIRT1) and matrix metalloproteinase-1 (MMP-1) in human intervertebral disc nucleus pulposus cells and to explore the effects of SIRT1 and MMP-1 on the development of the intervertebral disc degeneration. Intervertebral disc nucleus pulposus specimens from 41 patients who underwent lumbar protrusion resection at HuiZhou Municipal Central Hospital, during the period from October 2011 to December 2013, were studied in comparison with 23 control cases from patients who underwent fractured lumbar resection. In degenerated human intervertebral disc nucleus pulposus cells, the expression of SIRT1 is decreased and MMP-1 is increased compared with that of the control cells. Resveratrol could reverse these effects, thereby increasing the expression of SIRT1 (0.87 ± 0.07 vs 0.54 ± 0.04), Coll2α1 (0.90 ± 0.08 vs 0.38 ± 0.01), and aggrecan (0.69 ± 0.07 vs 0.42 ± 0.05) and decreasing the expression of MMP-1 (0.61 ± 0.03 vs 0.93 ± 0.08). These results suggest that resveratrol could possibly reverse the process of intervertebral disc degeneration and thus could be applied as a potential drug for the disease.


Assuntos
Regulação da Expressão Gênica/efeitos dos fármacos , Metaloproteinase 1 da Matriz/genética , Sirtuína 1/genética , Estilbenos/farmacologia , Adulto , Idoso , Agrecanas/metabolismo , Células Cultivadas , Colágeno Tipo II/metabolismo , Feminino , Humanos , Imuno-Histoquímica , Técnicas In Vitro , Masculino , Metaloproteinase 1 da Matriz/metabolismo , Pessoa de Meia-Idade , Reação em Cadeia da Polimerase , Resveratrol , Sirtuína 1/metabolismo , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA